The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice.

Autor: Harrington WW; Department of Metabolic Diseases, GlaxoSmithKline Research, Research Triangle Park, NC 27709, USA., S Britt C, G Wilson J, O Milliken N, G Binz J, C Lobe D, R Oliver W, C Lewis M, M Ignar D

Publikováno v: PPAR research [PPAR Res] 2007; Vol. 2007, pp. 97125.